Study finds Alzheimer’s drug Leqembi would cost Medicare up to $5 billion a year

According to a study led by researchers at UCLA, the Alzheimer’s drug Leqembi would raise future costs for Medicare by $2 billion to $5 billion a year. Leqembi, sold for […]

Study finds Alzheimer’s drug Leqembi would cost Medicare up to $5 billion a year Read More »